Results 191 to 200 of about 436,511 (214)
Some of the next articles are maybe not open access.
The Southeast Asian journal of tropical medicine and public health, 2015
The uniqueness of the dengue viruses (DENVs) and the spectrum of disease resulting from infection have made dengue vaccine development difficult. Several vaccine candidates are currently being evaluated in clinical studies. The candidate currently at the most advanced clinical development stage, a live-attenuated tetravalent vaccine based on the ...
Usa, Thisyakorn, Chule, Thisyakorn
openaire +1 more source
The uniqueness of the dengue viruses (DENVs) and the spectrum of disease resulting from infection have made dengue vaccine development difficult. Several vaccine candidates are currently being evaluated in clinical studies. The candidate currently at the most advanced clinical development stage, a live-attenuated tetravalent vaccine based on the ...
Usa, Thisyakorn, Chule, Thisyakorn
openaire +1 more source
Dengue vaccines: preparing to roll back dengue.
Current opinion in investigational drugs (London, England : 2000), 2003Dengue is an emerging viral pathogen of growing global importance, infecting up to 100 million people annually. Although there have been many efforts over the last six decades to produce a vaccine to combat this infection, few have been able to meet the challenges posed by the unusual interplay between this virus and its human host.
Jacobs, M., Young, P. R.
openaire +3 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2011
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
Targets and strategies for vaccine development against dengue viruses
Biomedicine and Pharmacotherapy, 2021Yenhsu Chen +2 more
exaly
Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
Nature Reviews Microbiology, 2015Bruno Guy
exaly